ArticleHeliyon2024
Research on the evolution mechanism of intelligent manufacturing transformation of Chinese pharmaceutical manufacturing enterprises based on system dynamics.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Under the impetus of the new industrial revolution, how to realize intelligent manufacturing transformation of traditional pharmaceutical manufacturing enterprises has realistic urgency. The study starts from the perspective of complex adaptive system, constructs a system dynamics model of the evolution mechanism of intelligent manufacturing transformation of pharmaceutical manufacturing enterprises based on technological adaptation and evolutionary adaptation, and analyzes it by simulation using Vensim PLE software. The results of the study show that pharmaceutical manufacturing enterprises utilize technological affordances to provide support to realize network product-based manufacturing capability and smart product-based manufacturing capability through technological innovation capability and institutional optimization capability; the technological affordances environment promotes the realization of intelligent manufacturing transformation of pharmaceutical manufacturing enterprises to present a stage transformation law. The study enriches and extends the research paradigm of intelligent manufacturing transformation, and provides a reference for pharmaceutical manufacturing enterprises to realize intelligent manufacturing transformation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.